Detalhe da pesquisa
1.
Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosis.
Antimicrob Agents Chemother
; 67(12): e0061123, 2023 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37971239
2.
Pharmacokinetics and Safety of Bedaquiline in Human Immunodeficiency Virus (HIV)-Positive and Negative Older Children and Adolescents With Rifampicin-Resistant Tuberculosis.
Clin Infect Dis
; 75(10): 1772-1780, 2022 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35377434
3.
Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis.
Antimicrob Agents Chemother
; 66(6): e0226421, 2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35506699
4.
Erratum for van der Laan et al., "Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis".
Antimicrob Agents Chemother
; 67(7): e0072023, 2023 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37338349
5.
Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis.
Front Pharmacol
; 12: 722204, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34690765
6.
Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis.
J Pediatric Infect Dis Soc
; 10(2): 201-204, 2021 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32448902